1518 related articles for article (PubMed ID: 18425114)
1. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.
Al-Nedawi K; Meehan B; Micallef J; Lhotak V; May L; Guha A; Rak J
Nat Cell Biol; 2008 May; 10(5):619-24. PubMed ID: 18425114
[TBL] [Abstract][Full Text] [Related]
2. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.
Wikstrand CJ; McLendon RE; Friedman AH; Bigner DD
Cancer Res; 1997 Sep; 57(18):4130-40. PubMed ID: 9307304
[TBL] [Abstract][Full Text] [Related]
3. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
4. Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance.
Weppler SA; Li Y; Dubois L; Lieuwes N; Jutten B; Lambin P; Wouters BG; Lammering G
Radiother Oncol; 2007 Jun; 83(3):333-9. PubMed ID: 17512071
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
6. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.
Allen C; Vongpunsawad S; Nakamura T; James CD; Schroeder M; Cattaneo R; Giannini C; Krempski J; Peng KW; Goble JM; Uhm JH; Russell SJ; Galanis E
Cancer Res; 2006 Dec; 66(24):11840-50. PubMed ID: 17178881
[TBL] [Abstract][Full Text] [Related]
7. VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells.
Tabatabai G; Herrmann C; von Kürthy G; Mittelbronn M; Grau S; Frank B; Möhle R; Weller M; Wick W
Brain; 2008 Oct; 131(Pt 10):2579-95. PubMed ID: 18689869
[TBL] [Abstract][Full Text] [Related]
8. Concealed cargo within the tumor microenvironment: microvesicles disseminate oncogenic receptors among cancer cells.
O'Connor R
Cancer Biol Ther; 2008 Sep; 7(9):1350-1. PubMed ID: 18972626
[No Abstract] [Full Text] [Related]
9. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles--vehicles that spread cancer genes.
Rak J; Guha A
Bioessays; 2012 Jun; 34(6):489-97. PubMed ID: 22442051
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
[TBL] [Abstract][Full Text] [Related]
12. Annexin A6 inhibits Ras signalling in breast cancer cells.
Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor in cancer.
Rak J; Milsom C; Yu J
Curr Opin Hematol; 2008 Sep; 15(5):522-8. PubMed ID: 18695378
[TBL] [Abstract][Full Text] [Related]
14. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
16. Lipid rafts enriched in phosphatidylglucoside direct astroglial differentiation by regulating tyrosine kinase activity of epidermal growth factor receptors.
Kinoshita MO; Furuya S; Ito S; Shinoda Y; Yamazaki Y; Greimel P; Ito Y; Hashikawa T; Machida T; Nagatsuka Y; Hirabayashi Y
Biochem J; 2009 May; 419(3):565-75. PubMed ID: 19170657
[TBL] [Abstract][Full Text] [Related]
17. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
Yang B; Chen J; Zhang X; Cao J
Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
[TBL] [Abstract][Full Text] [Related]
18. Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence.
Tchougounova E; Jiang Y; Bråsäter D; Lindberg N; Kastemar M; Asplund A; Westermark B; Uhrbom L
Oncogene; 2009 Mar; 28(12):1537-48. PubMed ID: 19219070
[TBL] [Abstract][Full Text] [Related]
19. Highlights of a new type of intercellular communication: microvesicle-based information transfer.
Pap E; Pállinger E; Pásztói M; Falus A
Inflamm Res; 2009 Jan; 58(1):1-8. PubMed ID: 19132498
[TBL] [Abstract][Full Text] [Related]
20. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.
Adams TE; Koziolek EJ; Hoyne PH; Bentley JD; Lu L; Lovrecz G; Ward CW; Lee FT; Scott AM; Nash AD; Rothacker J; Nice EC; Burgess AW; Johns TG
Growth Factors; 2009 Jun; 27(3):141-54. PubMed ID: 19333814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
